Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.58B |
| 2 |
Analog Devices
ADI
|
+$2.44B |
| 3 |
Tesla
TSLA
|
+$2.16B |
| 4 |
Amazon
AMZN
|
+$1.91B |
| 5 |
Airbnb
ABNB
|
+$1.46B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.74B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$3.09B |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.94B |
| 4 |
JD.com
JD
|
+$1.44B |
| 5 |
Oracle
ORCL
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.68% |
| 2 | Financials | 13.9% |
| 3 | Healthcare | 12.93% |
| 4 | Consumer Discretionary | 11.46% |
| 5 | Communication Services | 9.07% |
Similar funds
Vanguard Group's Q3 2021 Portfolio in Review
As of Q3 2021, Vanguard Group held 4,606 positions worth $4.03T, up 0.19% from $4.02T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Vanguard Group's Q3 2021 filing shows 181 new, 2,689 increased, 1,318 reduced and 61 closed positions. Its largest new stake was Lucid Motors: 3,551,262 shares worth $901M. The largest sale was Alexion Pharmaceuticals, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q3 2021 buy was Lucid Motors: 3,551,262 shares worth $901M.
- Vanguard Group added most to Moderna in Q3 2021, an estimated $2.58B increase.
- Vanguard Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $1.44B.
- Vanguard Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.74B.
- Vanguard Group's ten largest holdings make up 20% of its $4.03T portfolio in Q3 2021.
- Vanguard Group opened 181 new positions and closed 61 in Q3 2021.
- Vanguard Group's portfolio value rose 0.19% quarter-over-quarter to $4.03T.
Based on Vanguard Group's 13F filing for Q3 2021, filed 12 Nov 2021.